Primecap Management Co. CA grew its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 48.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 38,500 shares of the company’s stock after buying an additional 12,500 shares during the period. Primecap Management Co. CA’s holdings in Prestige Consumer Healthcare were worth $1,459,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Raymond James & Associates boosted its stake in shares of Prestige Consumer Healthcare by 36.1% during the 2nd quarter. Raymond James & Associates now owns 45,163 shares of the company’s stock worth $1,733,000 after buying an additional 11,989 shares during the last quarter. Rice Hall James & Associates LLC bought a new position in Prestige Consumer Healthcare in the 3rd quarter valued at about $4,305,000. Icon Advisers Inc. Co. grew its position in shares of Prestige Consumer Healthcare by 82.9% during the 3rd quarter. Icon Advisers Inc. Co. now owns 77,200 shares of the company’s stock worth $2,925,000 after purchasing an additional 35,000 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of Prestige Consumer Healthcare by 10.4% during the 2nd quarter. Janus Henderson Group PLC now owns 943,042 shares of the company’s stock worth $36,194,000 after purchasing an additional 88,822 shares in the last quarter. Finally, Flinton Capital Management LLC grew its position in shares of Prestige Consumer Healthcare by 32.0% during the 2nd quarter. Flinton Capital Management LLC now owns 31,776 shares of the company’s stock worth $1,220,000 after purchasing an additional 7,696 shares in the last quarter.
Shares of NYSE:PBH opened at $38.11 on Tuesday. Prestige Consumer Healthcare Inc has a 12-month low of $27.84 and a 12-month high of $48.24. The company has a market cap of $2.01 billion, a price-to-earnings ratio of 14.77, a price-to-earnings-growth ratio of 1.92 and a beta of 1.01. The company has a current ratio of 2.15, a quick ratio of 1.38 and a debt-to-equity ratio of 1.59.
A number of research analysts have issued reports on the stock. ValuEngine lowered shares of Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 16th. Zacks Investment Research restated a “hold” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, November 14th. Finally, DA Davidson increased their target price on shares of Prestige Consumer Healthcare to $38.00 and gave the stock a “neutral” rating in a research report on Monday, November 5th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $39.67.
In other Prestige Consumer Healthcare news, EVP Timothy Connors sold 34,000 shares of the stock in a transaction that occurred on Monday, November 19th. The shares were sold at an average price of $38.25, for a total transaction of $1,300,500.00. Following the transaction, the executive vice president now owns 25,775 shares in the company, valued at approximately $985,893.75. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.14% of the company’s stock.
Prestige Consumer Healthcare Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Further Reading: Stock Split
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.